Tailored Pharmacist-led Intervention to Improve Adherence to Budesonide in Asthmatic Children
Gaining control of asthma can be especially difficult during childhood as children undergo a variety of biological, developmental, and psychosocial changes. This study was designed to evaluate the impact of a pharmacist-led patient-centered medication therapy management trial on asthma and medication adherence among children receiving budesonide at a tertiary hospital in Shaoxing, China. In this randomised controlled trial, one hundred and two children, with asthma, from 6 to 14 age, will be recruited and randomised to an intervention group or a control group. The intervention group will receive a pharmacist-driven discharge counseling on budesonide, an inhaled glucocorticoid, from recruitment, until 12 months. The control group will receive care as usual. The main outcomes were spirometry measurements and medication adherence estimation.
• 6-14 years-of-age
• Met the diagnostic criteria described by the Recommendations for Standardized Diagnosis and Treatment of Bronchial Asthma in Children (2020 Edition)
• Dysfunctional lung function with a positive provocation test
• No previous respiratory rehabilitation treatment
• The parents' written informed consent.